Results 91 to 100 of about 379,801 (144)

Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines. [PDF]

PLoS Pathog, 2022
Elliott T, Cheeseman HM, Evans AB, Day S, McFarlane LR, O'Hara J, Kalyan M, Amini F, Cole T, Winston A, Fidler S, Pollock KM, Harker JA, Shattock RJ.   +13 more
europepmc   +1 more source

Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination

Frontiers in Immunology
To address the COVID-19 pandemic, diverse vaccination strategies, including homologous and heterologous schedules, were employed to enhance immune protection.
Davide Torre, Chiara Orlandi, Chiara Orlandi, Ilaria Conti, Simone Barocci, Eugenio Carlotti, Mauro Magnani, Mauro Magnani, Anna Casabianca, Anna Casabianca, Giuseppe Stefanetti, Giuseppe Stefanetti   +11 more
doaj   +1 more source

Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2. [PDF]

Vaccines (Basel), 2022
Markewitz RDH, Juhl D, Pauli D, Görg S, Junker R, Rupp J, Engel S, Steinhagen K, Herbst V, Zapf D, Krüger C, Brockmann C, Leypoldt F, Dargvainiene J, Schomburg B, Sharifzadeh SR, Salek Nejad L, Wandinger KP, Ziemann M.   +18 more
europepmc   +1 more source

Modified live PRRS vaccination provides heterologous protection against virulent 1-18-2 challenge

, 2009
Jordan, D.; Layton, S.; Philips, R.; Genzow, M.. (2009). Modified live PRRS vaccination provides heterologous protection against virulent 1-18-2 challenge.
Genzow, M., Philips, R., Jordan, D., Layton, S.   +3 more
core  

Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao. [PDF]

Front Immunol, 2023
Ng HM, Lei CL, Fu S, Li E, Leong SI, Nip CI, Choi NM, Lai KS, Tang XJ, Lei CL, Xu RH.   +10 more
europepmc   +1 more source

Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding

npj Vaccines
Booster vaccinations are recommended to improve protection against severe disease from SARS-CoV-2 infection. With primary vaccinations involving various adenoviral vector and mRNA-based formulations, it remains unclear if these differentially affect the ...
Gemma E. Hartley, Holly A. Fryer, Paul A. Gill, Irene Boo, Scott J. Bornheimer, P. Mark Hogarth, Heidi E. Drummer, Robyn E. O’Hehir, Emily S. J. Edwards, Menno C. van Zelm   +9 more
doaj   +1 more source

Neutralizing antibodies levels are increased in individuals with heterologous vaccination and hybrid immunity with Ad5-nCoV in the north of Mexico. [PDF]

PLoS One, 2022
Cervantes-Luevano K, Espino-Vazquez AN, Flores-Acosta G, Bernaldez-Sarabia J, Cabanillas-Bernal O, Gasperin-Bulbarela J, Gonzalez-Sanchez R, Comas-Garcia A, Licea-Navarro AF.   +8 more
europepmc   +1 more source

Neonatal BCG vaccination influences cytokine responses to toll-like receptor ligands and heterologous antigens

, 2018
Background: BCG vaccination is associated with a reduction in all-cause infant mortality in high-mortality settings. The underlying mechanisms remain uncertain, but long-term modulation of the innate immune response (trained immunity) may be involved.
Gardiner, K (15686276), Katie Flanagan (14736613), Casalaz, D (15686279), Netea, MG (15676772), Kollmann, T (15686291), Robins-Browne, RM (15686282), Amenyogbe, N (15686285), Donath, S (15686270), Freyne, B (15686267), Germano, S (15686273), Curtis, N (15686294), Messina, NL (15686288)   +11 more
core  

Neonatal BCG vaccination reduces interferon-γ responsiveness to heterologous pathogens in infants from a randomized controlled trial

, 2020
Background: BCG vaccination has beneficial nonspecific (heterologous) effects that protect against nonmycobacterial infections. We have previously reported that BCG vaccination at birth alters in vitro cytokine responses to heterologous stimulants in the
Gardiner, K (15686276), Katie Flanagan (14736613), Bonnici, R (15748811), Casalaz, D (15686279), Netea, MG (15676772), Kollmann, T (15686291), Robins-Browne, RM (15686282), Donath, S (15686270), Freyne, B (15686267), Germano, S (15686273), Curtis, N (15686294), Messina, NL (15686288)   +11 more
core  

Newborns' passive humoral SARS-CoV-2 immunity following heterologous vaccination of the mother during pregnancy. [PDF]

Am J Obstet Gynecol, 2022
Gloeckner S, Hornung F, Heimann Y, Schleussner E, Deinhardt-Emmer S, Loeffler B, Zoellkau J.   +6 more
europepmc   +1 more source